Narvitas Presentation

•Download as PPTX, PDF•

1 like•312 views

This document summarizes a corporate presentation for Narvitas Medical Devices. It introduces a new medical device called LapDome that improves the standard procedure for gaining abdominal access during laparoscopic surgeries. The presentation outlines the clinical need, opportunity, solution, intellectual property protection, management team, advisors, distribution strategy, product pipeline, and financial projections. It indicates the company aims to develop, patent, manufacture and sell proprietary medical devices, with an initial focus on devices for laparoscopic surgery and epidural anesthesia.

Healthcare

Clinical Problem
• Initial Access using a Veress needle has not
changed in 30 years
• Complications rates are frequent and very
expensive
• Time to insufflation!

Opportunity
• Simple innovation to allow safe and fast access
to abdomen
• 9 million procedures using Veress needle
every year
• Growing 10% per annum
• Distributor friendly single use device

Solution – ‘LapDome’
• Clinical superiority
• Improves current standard of care
• Improves patient safety
• Improved insufflation rates
• Reduced operating theatre budgets
• Reducing potential complications
rates

Narvitas Medical Devices
• Develop, patent, manufacture and sell propriety medical
devices
• 3 Initial Platforms, each leveraging the core technology
• Class 1 - Large market segment – High Volume procedures
Laparoscopic Epidural Anesthesia Med
Surg
15 mil procedures
worldwide
130 mil births In dwelling catheter
collection
EpiDome Jaws

Team
Glenn Foley Co-Founder & CEO
AVE – Medtronic -
Precision Vascular
Daragh Sharkey Co-Founder & Director
Sales Mkt and Bus Dev
Aerogen, Altana, Trojan Med
Arthur Malvett Co-Founder & Director
Operations and Logistics
Life Care Medical, Midland
Bank

Advisors
• Dr. Aidan Sharkey
– Consultant Anesthetist UCHG – Specialty OBGYN
• Dr. Una Conway
– Consultant OBGYN – Specialty in Laparoscopic Surgery
• Dr. Michael O’Dowd
– Retired Consultant OBGYN – Pioneered Laparoscopic Surgery in UK / Irl –
Author of 3 medical texts and numerous research papers
• Mr. Jerome Nathan
– CFO Centilex Corp, LLB University Paris, ACCA University Paris
• Mr. Alan Crean
– CEO Poly Pico Medical, CEO Pointec Medical, Director Creganna

Professional Advisors
€452k
Subscribed
€298k
Open
€2.3m
Valuation

Intellectual Property
Laparoscopic Surgery
National Phase Patent Application Number Patent Publication Number
US 13/640,015 US2013-0197315A1
Europe 10849757.9 EP2558006A1
Japan P2013-504347 P2013-523370A
Australia 2010351314
AU2010351314A1
South Korea 10-2012-7029658 10-20-130076816
UK GB1408740.7
Epidural Anesthesia
UK GB1409553.3

Distributor Strategy - EMEA
• UK, Ireland, Benelux Q2 – key hospitals and doctors identified
• Key distributors identified – specific expertise in GYN medical devices
• Clinical Backup
• Enterprise Ireland support and back up – key meetings, distributor
selection
• Strategic focus on UAE / Saudi Arabia

Distributor Strategy - USA
• US Laparoscopic Surgery Veress based procedure volume: 6,000,000 procedures
Surgical Principals Inc Active Medical
EA Medical AMSC
CS Surgical Adler Instruments
Mediflex USA
Support Programs
• Europe/ME referral centers
• White papers
• Registry
• Published papers
• Economic Impact analysis

Product Pipeline and Timing
Device Class CE FDA JMOH
I CQI 2015 CQ4 2015 CQI 2016
2A Kits inc Veress CQ4 2015 CQ2 2016 CQ4 2016
EpiDome
CQ3 2015
CQ4 2015
CQI 2016
CQ1 2016
CQ1 2016
CQ3 2016
CQ2 2016
CQ2 2016
CQ4 2016

Financial Forecast
FY2015* FY2016** FY2017***
Sales Revenue €0 €1,585 €9,721
CGS €0 €287 €2,149
GP €0 €1,261 €7,419
OPEX €-232 €459 €1,116
EBITDA €-238 €802 (52%) €6,375 (66%)
* Europe
** Europe +US + Latin America
*** Europe +US + Latin America + Japan

- Narvitas Medical Devices develops proprietary medical devices to improve laparoscopic and epidural procedures. - Their first product, LapDome, provides safer and faster abdominal access during laparoscopic surgery compared to current Veress needle methods, addressing a $15 million market that is growing 8.3% annually. - The management team has experience in medical device companies and regulatory approval processes. Financial projections estimate positive EBITDA by 2016 and growing profits through 2017 as the company expands into new markets.

Scan4Safety - Positive Patient ID

Carol Read

Presenter Slides - Matthew Ginn, Proximie

Health Innovation Wessex

This document discusses Proximie, a technology solution that enables remote clinical collaboration. It highlights key issues like lack of access to surgical care globally and unequal healthcare availability. Proximie aims to address this through an augmented reality platform that allows clinicians to interact live and access a library of recorded content. Examples demonstrate how Proximie has enabled remote proctoring of new surgical techniques and consultations between hospitals to improve patient experience and healthcare access in rural communities.

Dr Liz Mear - Welcome to Ecosystem 11 - Digital Innovation in Medicines Optim...

Innovation Agency

Julie Evason - Procure into the NHS: A Small Business Perspective

Innovation Agency

Narvitas_Pres_Rev_2_April_2015

Narvitas Medical Devices Ltd.

1) Narvitas Medical Devices develops, patents, manufactures and sells proprietary medical devices across 3 initial platforms leveraging a core technology. 2) The management team includes co-founders with experience at large medical device companies and a hospital. 3) The company is developing a new modality called LapDome to improve laparoscopic surgery by providing a safer alternative to the standard Veress needle technique for pneumoperitoneum. 4) Narvitas is working with engineering design firms to develop initial devices and has filed for intellectual property protection.

C-TRIC 2011

BarryHenderson

C-TRIC is Northern Ireland's only purpose-built clinical research facility located within the Western Health and Social Care Trust, University of Ulster, and Derry City Council. It provides 9,000 square feet for clinical research studies, pharmaceutical trials, and evaluation of medical devices. C-TRIC offers clinical research services through its clinical research facility, nurse team, and support for areas like study design and data analysis. It also operates a healthcare innovation hub that provides workspace and incubation support to companies conducting research in areas like diabetes, cardiology, oncology, and more. C-TRIC has been involved in numerous clinical studies and works to facilitate translational research across disease areas through collaboration between academics and clinicians.

CV M Dutto_ 2015

Massimo Dutto

Massimo Dutto has over 20 years of experience in biomedical clinical engineering and management. He is currently a biomedical clinical engineer at The Royal Brompton and Harefield Hospital NHS Trust in London, where he manages medical devices and researches, designs, and develops new medical products. Previously, he held roles as a biomedical senior clinical engineer at Azienda Ospedliera S.Croce e Carle hospital in Italy and as a senior manager of steam power generators at Michelin in Italy. He has an MSc in Biomedical Engineering from City University London and qualifications in electrical engineering, electronics, and programming.

This document discusses CHKS Accreditation in Primary Health Care. CHKS provides data benchmarking and healthcare accreditation services in the UK and Europe. They work with over 100 hospitals and primary care clients. The document outlines CHKS's accreditation cycle, which involves an initial assessment against standards, followed by surveillance visits at 12 and 24 months and a monitoring visit at 18 months if not pursuing ISO certification. Accreditation is granted for three years from the date of the initial assessment. The primary health care accreditation standards focus on patient safety, experience, clinical governance and leadership.

30.03.2015 Brief Introduction of Intermed Hospital, Bolormaa Tumendemberel

The Business Council of Mongolia

This document provides an introduction and overview of a hospital project in Mongolia. It discusses the project timeline and goals, including establishing a modern hospital to international standards with advanced technologies. The hospital infrastructure is described as the first in the country to meet European standards, with features like infection prevention systems and an advanced building management system. Clinical services, medical specialties, and a professional team of local and foreign doctors and nurses are outlined. The hospital aims for clinical excellence through practices like evidence-based guidelines. Customer services and partnerships are also summarized.

#MWC15Health Katrina Delargy mPowering the doctor patient relationship

3GDR

This document summarizes presentations from several digital health innovators at a conference. It includes: 1) Three companies showcasing mobile technologies to improve doctor-patient communication and provide remote patient monitoring. This includes chatbots, real-time location tracking wristbands, and SMS programs. 2) A company demonstrating a low-cost mobile diagnostic tool using a phone camera to detect biomarkers for multiple sclerosis medication management. 3) A company discussing how personalized nutrition therapy can be delivered using digital tools.

Carlos Rodrigues, GenesisCare, International.

GenesisCareUK

The document discusses improving radiotherapy efficiency in Spain while maintaining quality and access. It addresses balancing efficiency, quality, and access. Some key points discussed include: - GenesisCare has a presence in 5 Spanish regions with 11 radiotherapy centers and a heterogeneous fleet of equipment. - Efficiency does not just define the current state but also the ability to adapt quickly to changes, which is an important "future-readiness" metric. - Maintaining state-of-the-art techniques for all patients requires addressing unacceptable maintenance schedules and downtimes. - Ways to improve efficiency discussed include developing internal expertise through standardization and automation, creating a coherent technical platform, and upgrading infrastructure through investments. Specific examples provided

Dr Mark Jackson - Innovation Scouts: what's the deal?

Innovation Agency

HSF_Hospedia_Presentation October 2016

Stuart Watkins

This document summarizes a presentation about using health informatics to improve patient flow. It discusses how inefficient patient flow can lead to delays, longer lengths of stay, and poorer patient care and experience. The presentation describes how seamless patient flow between primary care, acute care, community care, and social care requires tightly integrated care models with shared tools, communication, and monitoring across settings. Case studies are presented of two UK hospitals that implemented Hospedia's ExtraMed patient flow solution and achieved benefits like reduced emergency department wait times, fewer delayed discharges, and improved compliance with targets.

Business model for single port robotic surgery

Jaya lakshmi Mekala

Single port robotic surgery is gaining popularity due to its benefits over traditional multi-port surgery. A business model and value proposition canvas were created to outline the market opportunity for single port robotic surgery devices. Key opinion leaders and clinical associations were identified as important sources of information to educate medical professionals and accelerate adoption of new technologies. The canvases were modified based on feedback to address user adoption barriers, costs, data management, and focus on continuous research collaboration between doctors and engineers to further develop safe, minimally invasive surgical robotics.

The Future of Digital Health and Wearables in Orthopedicsrables

April Bright

Orthopedic device companies have responded to payors’ adoption of bundled payments and FDA’s promotion of digital health tools by commercializing products that track patients beyond the O.R. Digital health tools, including wearables, provide device companies with revenue streams that respond to hospitals’ episode of care requirements and patients’ personalized medicine needs, while simultaneously creating a feedback loop for product ideas. Christopher E. Pelt, M.D., a surgeon enrolled in Zimmer Biomet’s mymobility clinical study with the Apple Watch app, offered perspective on the benefits of wearables and shares ways that the technology will impact patients, surgeons and device companies in the future.

Alcon

Healthegy

The document discusses accelerating innovation in ophthalmology. It notes that innovation requires focusing on patient needs, organizing for success, and making thoughtful choices regarding product innovation, disruptive platforms, delivery models, and other areas. Specific examples are provided of Alcon's innovations in cataract surgery, glaucoma surgery, vitreoretinal surgery, refractive surgery, and retinal pharmaceuticals. Alcon's collaboration with Google on non-invasive sensors and microchips is also mentioned as a potential disruptive platform.

Transcend Medical

Healthegy

The document discusses micro-invasive glaucoma surgery (MIGS) and the CyPass micro-stent developed by Transcend Medical for treating glaucoma. It provides an overview of CyPass' development from 2005 to 2015, including pilot studies, ongoing clinical trials in the US and EU, and preliminary positive results showing reduced intraocular pressure. The document also discusses the potential of MIGS generally and CyPass specifically to provide an alternative between eye drop medications and more invasive surgeries like trabeculectomy for treating glaucoma.

PaulStephensonNSMReading

Paul Stephenson

This document discusses a new sales development role for a critical care catheter called the Angel Catheter. The role would help overcome challenges of bringing new technologies to the NHS market. It would do this by spreading awareness of the catheter's benefits using national funding codes rather than departmental budgets. It would also promote how the catheter could help hospitals meet quality guidelines and safety audits. The role would require networking across different hospital departments and organizations that could impact sales beyond just interventionalists. The health market is dynamic, so the role would focus on establishing relationships with key decision-makers and supporting new technologies.

Bio2016 Invest NI Breakfast Presentation 8th June

Barry Henderson

Northern Ireland has a highly educated workforce with over 52,000 undergraduate and postgraduate students studying life and health sciences subjects. It has a world-class scientific research base focused on areas like oncology, inflammation, and diabetes. Northern Ireland has high quality clinical data and materials available through its integrated health service, including an electronic health record system and biobank. It offers an innovation-friendly healthcare system and support programs to help commercialize innovations, including the Precision Medicine Testbed and Connected Health Innovation Centre. Northern Ireland provides attractive incentives for companies through Invest NI, including grants, tax credits, and infrastructure support.

14.45 global digital exemplars janice sigsworth deborah sanders jacqui coop...

NHS England

Janice Sigsworth discusses Imperial College Healthcare NHS Trust's digital strategy and journey over the past several years, including implementing order communications, a patient administration system, clinical documentation, e-prescribing, and trustwide rollouts of technology. Deborah Sanders discusses Royal Free London NHS Foundation Trust's partnership with DeepMind to develop an acute kidney injury alert system using artificial intelligence. Jacqui Cooper and Paul Jones compare Estonia's digital healthcare system to initiatives at Wirral University Teaching Hospital NHS Foundation Trust, where they have implemented digital technologies and been recognized as a Global Digital Exemplar.

CBCC Global Presentation

Harini Patel

1) CBCC was founded in 1984 in California as a small cancer clinic and has since expanded to become one of the largest cancer care providers in North America and India, operating multiple centers with over 30 oncologists and providing care and clinical trials to thousands of patients annually. 2) The document provides details on CBCC's centers and operations in the US and India, including locations, services, numbers of patients and clinical trials conducted across various cancer types. 3) CBCC has extensive experience conducting oncology clinical trials, with a focus on trials for breast, lung, ovarian and other cancers, and has participated in trials for many now-approved drugs through their affiliation with UCLA.

Final presentation introduction_of_the_i_stat_analyser_at_the_vale_activity_22

Charlie Houston MSc CSci MIBMS

This document proposes introducing the iSTAT point-of-care testing system at Vale of Leven Hospital to perform electrolyte and renal function tests out of hours, in order to save money and comply with working hours regulations. It outlines the current point-of-care options available, identifies the gap in not having electrolyte testing, and compares three options - maintaining the current out-of-hours laboratory system, using the iSTAT system, or awaiting new tests for the existing Gem analyzer. Costs and benefits of the iSTAT system are presented, showing an estimated first year net savings of £27,694 compared to current costs. Risks around staff satisfaction and increased demand are also discussed.

Extreme Makeover: Healthcare Edition

Array Architects

A Collaborative Model for Continued Professional Development

GenesisCareUK

This document discusses a collaborative model for continued professional development (CPD). It proposes creating a centralized CPD platform to improve efficiency by allowing healthcare professionals to record their CPD activities in one place aligned with the standards of different regulatory bodies. An audit would first analyze CPD practices at sample centers in the UK, Australia and Spain to inform the design of categories and tools on the platform. Individuals and organizations would benefit from collaborating to improve CPD through a shared online platform.

Can Pushing help our ED PET

Eugene Farrell

This document discusses improving patient experience times (PET) in emergency departments (ED). It outlines the current poor ED PET performance nationally and at example hospitals. Reasons for delays include medical personnel, bed capacity, and delayed radiology and laboratory results. The document proposes introducing push notifications to alert clinicians when radiology and laboratory results are available to reduce waiting times. It discusses reengineering the process, conducting a pilot, and implementing change while managing resistance from stakeholders. The goal is to improve the patient experience and flow through EDs.

2015 Intelligent Health Association Award

Ashley Fontenot

The University of Tennessee Medical Center partnered with DeRoyal Industries to introduce radio frequency identification (RFID) technology in operating rooms to track surgical supplies. RFID tags on supplies provide automated tracking of item details like usage, location, expiration and lot numbers. This collaboration has led to improved operating room efficiencies like a 99% read rate of supplies and better separation of waste. Based on the success of this innovative technology, DeRoyal nominated UT Medical Center for an award, which it has received, recognizing healthcare institutions that implement technologies to improve patient safety, supply chain and asset management.

Varian 360 Oncology and GenesisCare, Oxford

GenesisCareUK

Implementing oesphageal Doppler in Enhanced Recovery

University of Manchester

This document discusses the implementation of oesophageal Doppler monitoring (ODM) to guide fluid administration for major surgery patients at three NHS hospitals between 2008-2009. It finds that using ODM: 1) Reduced length of hospital stay by 4 days on average and critical care use by 17-42% compared to pre-implementation patients. 2) Decreased complication rates like re-admission by 25% and re-operation by 43%. 3) Was successfully adopted through engaging management and clinicians, training staff, and demonstrating improved outcomes from a controlled initial rollout.

Healthtech Innovation QLD 9 Dec14 event

healthtechInnovationQLD

The document summarizes presentations from startups at a Healthtech Innovation Queensland event. It introduces QHeart Medical, which is developing a device called BioQ CA to treat heart failure by reducing aortic stiffness. GravityFit was presented as developing an exercise system based on 30 years of research into the sensory effect of gravity. The document also summarizes Audeara, which is creating an autonomous ear screening device to address the problem of high rates of ear disease, particularly in remote communities.

What's hot

Moyra Amess, Associate Director, CHKS

Investnet

30.03.2015 Brief Introduction of Intermed Hospital, Bolormaa Tumendemberel

The Business Council of Mongolia

#MWC15Health Katrina Delargy mPowering the doctor patient relationship

3GDR

Carlos Rodrigues, GenesisCare, International.

GenesisCareUK

Dr Mark Jackson - Innovation Scouts: what's the deal?

Innovation Agency

HSF_Hospedia_Presentation October 2016

Stuart Watkins

Business model for single port robotic surgery

Jaya lakshmi Mekala

The Future of Digital Health and Wearables in Orthopedicsrables

April Bright

Alcon

Healthegy

Transcend Medical

Healthegy

PaulStephensonNSMReading

Paul Stephenson

Bio2016 Invest NI Breakfast Presentation 8th June

Barry Henderson

14.45 global digital exemplars janice sigsworth deborah sanders jacqui coop...

NHS England

CBCC Global Presentation

Harini Patel

Final presentation introduction_of_the_i_stat_analyser_at_the_vale_activity_22

Charlie Houston MSc CSci MIBMS

Extreme Makeover: Healthcare Edition

Array Architects

A Collaborative Model for Continued Professional Development

GenesisCareUK

Can Pushing help our ED PET

Eugene Farrell

2015 Intelligent Health Association Award

Ashley Fontenot

Varian 360 Oncology and GenesisCare, Oxford

GenesisCareUK

What's hot (20)

Moyra Amess, Associate Director, CHKS

30.03.2015 Brief Introduction of Intermed Hospital, Bolormaa Tumendemberel

#MWC15Health Katrina Delargy mPowering the doctor patient relationship

Carlos Rodrigues, GenesisCare, International.

Dr Mark Jackson - Innovation Scouts: what's the deal?

HSF_Hospedia_Presentation October 2016

Business model for single port robotic surgery

The Future of Digital Health and Wearables in Orthopedicsrables

Alcon

Transcend Medical

PaulStephensonNSMReading

Bio2016 Invest NI Breakfast Presentation 8th June

14.45 global digital exemplars janice sigsworth deborah sanders jacqui coop...

CBCC Global Presentation

Final presentation introduction_of_the_i_stat_analyser_at_the_vale_activity_22

Extreme Makeover: Healthcare Edition

A Collaborative Model for Continued Professional Development

Can Pushing help our ED PET

2015 Intelligent Health Association Award

Varian 360 Oncology and GenesisCare, Oxford

smuskaan0008

GEMMA Wean is a high end larval co-feeding and weaning diet aimed at Artemia optimisation and is fortified with a high level of proteins and phospholipids. GEMMA Wean provides the early weaned juveniles with dedicated fish nutrition and is an ideal follow on from GEMMA Micro or Artemia. GEMMA Wean has an optimised nutritional balance and physical quality so that it flows more freely and spreads readily on the water surface. The balance of phospholipid classes to- gether with the production technology based on a low temperature extrusion process improve the physical aspect of the pellets while still retaining the high phospholipid content. GEMMA Wean is available in 0.1mm, 0.2mm and 0.3mm. There is also a 0.5mm micro-pellet, GEMMA Wean Diamond, which covers the early nursery stage from post-weaning to pre-growing.

Professional Secrecy: Forensic Medicine Lecture

DIVYANSHU740006

TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...

rightmanforbloodline

Pediatric Emergency Care for Children | Apollo Hospital

Apollo 24/7 Adult & Paediatric Emergency Services

At Apollo Hospital, Lucknow, U.P., we provide specialized care for children experiencing dehydration and other symptoms. We also offer NICU & PICU Ambulance Facility Services. Consult our expert today for the best pediatric emergency care. For More Details: Map: https://cutt.ly/BwCeflYo Name: Apollo Hospital Address: Singar Nagar, LDA Colony, Lucknow, Uttar Pradesh 226012 Phone: 08429021957 Opening Hours: 24X7

Innovative Minds France's Most Impactful Healthcare Leaders.pdf

eurohealthleaders

Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)

bkling

GIT BS.pptx about human body their structure and

MuzafarBohio

CANSA support - Caring for Cancer Patients' Caregivers

CANSA The Cancer Association of South Africa

Recently uploaded (20)

HUMAN BRAIN.pptx.PRIYA BHOJWANI@GAMIL.COM

practical guide of obesityfinal hyper1د حاتم البيطار القمة اكاديمي 0120238902...

Luxurious Spa In Ajman Chandrima Massage Center

一比一原版(USF毕业证)旧金山大学毕业证如何办理

U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf

Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf

Top Rated Massage Center In Ajman Chandrima Spa

Hypertension and it's role of physiotherapy in it.

Get Covid Testing at Fit to Fly PCR Test

Friendly Massage in Ajman - Malayali Kerala Spa Ajman

MYASTHENIA GRAVIS POWER POINT PRESENTATION

chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf

Gemma Wean- Nutritional solution for Artemia

Professional Secrecy: Forensic Medicine Lecture

TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...

Pediatric Emergency Care for Children | Apollo Hospital

Innovative Minds France's Most Impactful Healthcare Leaders.pdf

Let's Talk About It: Breast Cancer (What is Mindset and Does it Really Matter?)

GIT BS.pptx about human body their structure and

CANSA support - Caring for Cancer Patients' Caregivers

Narvitas Presentation

1. Corporate Presentation January 2015

2. Clinical Problem • Initial Access using a Veress needle has not changed in 30 years • Complications rates are frequent and very expensive • Time to insufflation!

3. Opportunity • Simple innovation to allow safe and fast access to abdomen • 9 million procedures using Veress needle every year • Growing 10% per annum • Distributor friendly single use device

4. Solution – ‘LapDome’ • Clinical superiority • Improves current standard of care • Improves patient safety • Improved insufflation rates • Reduced operating theatre budgets • Reducing potential complications rates

5. Narvitas Medical Devices • Develop, patent, manufacture and sell propriety medical devices • 3 Initial Platforms, each leveraging the core technology • Class 1 - Large market segment – High Volume procedures Laparoscopic Epidural Anesthesia Med Surg 15 mil procedures worldwide 130 mil births In dwelling catheter collection EpiDome Jaws

6. Team Glenn Foley Co-Founder & CEO AVE – Medtronic - Precision Vascular Daragh Sharkey Co-Founder & Director Sales Mkt and Bus Dev Aerogen, Altana, Trojan Med Arthur Malvett Co-Founder & Director Operations and Logistics Life Care Medical, Midland Bank

7. Advisors • Dr. Aidan Sharkey – Consultant Anesthetist UCHG – Specialty OBGYN • Dr. Una Conway – Consultant OBGYN – Specialty in Laparoscopic Surgery • Dr. Michael O’Dowd – Retired Consultant OBGYN – Pioneered Laparoscopic Surgery in UK / Irl – Author of 3 medical texts and numerous research papers • Mr. Jerome Nathan – CFO Centilex Corp, LLB University Paris, ACCA University Paris • Mr. Alan Crean – CEO Poly Pico Medical, CEO Pointec Medical, Director Creganna

8. Professional Advisors €452k Subscribed €298k Open €2.3m Valuation

9. Intellectual Property Laparoscopic Surgery National Phase Patent Application Number Patent Publication Number US 13/640,015 US2013-0197315A1 Europe 10849757.9 EP2558006A1 Japan P2013-504347 P2013-523370A Australia 2010351314 AU2010351314A1 South Korea 10-2012-7029658 10-20-130076816 UK GB1408740.7 Epidural Anesthesia UK GB1409553.3

10. Distributor Strategy - EMEA • UK, Ireland, Benelux Q2 – key hospitals and doctors identified • Key distributors identified – specific expertise in GYN medical devices • Clinical Backup • Enterprise Ireland support and back up – key meetings, distributor selection • Strategic focus on UAE / Saudi Arabia

11. Distributor Strategy - USA • US Laparoscopic Surgery Veress based procedure volume: 6,000,000 procedures Surgical Principals Inc Active Medical EA Medical AMSC CS Surgical Adler Instruments Mediflex USA Support Programs • Europe/ME referral centers • White papers • Registry • Published papers • Economic Impact analysis

12. Product Pipeline and Timing Device Class CE FDA JMOH I CQI 2015 CQ4 2015 CQI 2016 2A Kits inc Veress CQ4 2015 CQ2 2016 CQ4 2016 EpiDome CQ3 2015 CQ4 2015 CQI 2016 CQ1 2016 CQ1 2016 CQ3 2016 CQ2 2016 CQ2 2016 CQ4 2016

13. Financial Forecast FY2015* FY2016** FY2017*** Sales Revenue €0 €1,585 €9,721 CGS €0 €287 €2,149 GP €0 €1,261 €7,419 OPEX €-232 €459 €1,116 EBITDA €-238 €802 (52%) €6,375 (66%) * Europe ** Europe +US + Latin America *** Europe +US + Latin America + Japan

14. Liquidity and Exit

Narvitas Presentation

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Narvitas Presentation

Similar to Narvitas Presentation (20)

Recently uploaded

Recently uploaded (20)

Narvitas Presentation